Par Pharmaceutical Inc v. Pfizer Inc
Par Pharmaceutical Inc v. Pfizer Inc is a federal patent - anda lawsuit filed on 01/22/2019 in the District Court, S.D. New York. The case was terminated on 03/15/2019.
- Court
- District Court, S.D. New York (S.D.N.Y.)
Official Court Website → - Assigned judge
- William H. Pauley, III · 3,213 cases in index
- Docket number
- 1:19-cv-00615
- Cause
- 28:2201dj Declaratory Judgment
28 U.S.C. § 2201dj - Nature of suit
- 835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 01/22/2019
- Date terminated
- 03/15/2019
16 Patent - ANDA cases in this court are indexed here.
Parties
- plaintiff · Par Pharmaceutical, Inc · 137 cases
- defendant · Pfizer, Inc Pharmaceuticals & Biotechnology · 12528 cases
Part of a Larger Litigation Pattern
This is one of 12,529 Patent - ANDA cases in our index naming Pfizer, Inc — a possible mass-tort or coordinated-litigation cluster.
About Patent - ANDA Lawsuits
ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
Frequently Asked Questions
What is Par Pharmaceutical Inc v. Pfizer Inc?
Par Pharmaceutical Inc v. Pfizer Inc is a federal patent - anda lawsuit filed on 01/22/2019 in the District Court, S.D. New York. The case was terminated on 03/15/2019. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What type of case is this?
It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What court is the case in?
The case is in the District Court, S.D. New York, docket number 1:19-cv-00615.
When was the case filed?
Par Pharmaceutical Inc v. Pfizer Inc was filed on 01/22/2019. It was terminated on 03/15/2019.
What law is the case brought under?
The docket lists the cause as 28 U.S.C. § 2201dj.
Other Cases Involving These Parties
Related Patent - ANDA Cases
Source: public U.S. federal court record (docket 13750173).